PM Modi Launches NexCAR19:
Prime Minister Narendra Modi has launched NexCAR19, India’s first indigenous CAR T-cell therapy, aimed at revolutionizing cancer treatment. Developed through a collaborative effort between ImmunoACT, IIT Bombay, and Tata Memorial Hospital, with support from DBT (Department of Biotechnology) and BIRAC (Biotechnology Industry Research Assistance Council), NexCAR19 positions India firmly on the global map of cell and gene therapy innovation.NexCAR19 is a form of CAR T-cell therapy—a cutting-edge treatment where a patient’s own T-cells (a type of white blood cell) are genetically modified to express Chimeric Antigen Receptors (CARs). These modified cells can specifically identify and attack cancer cells, offering targeted and highly effective treatment. The therapy is specifically developed to treat B-cell blood cancers, including, Leukemia, Lymphoma. It is especially beneficial for patients whose cancers have relapsed or failed to respond to traditional first-line treatments like chemotherapy or radiation.
